What does Pharis do?
PHARIS is a company specializing in the development and commercialization of innovative pharmaceutical products. It focuses on enhancing patient care through research and advanced healthcare solutions. The company aims to address unmet medical needs and improve treatment outcomes across various therapeutic areas.
- Sectors
- Real estate agencies
- Signals
-
Poor liquidityPoor liquidity 0.79
The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 1.86MThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 5.56MStrong equity provides a buffer against setbacks.
Low riskLow risk 61.6%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 2.01MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 587KPositive EBITDA: operating activities are profitable.
- Investments
- Craenenburg 100%, La Civiere D'or 99,9%, Cafe Du Theatre 99%, +2 more
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
610K
|
€
397K
|
€
451K
|
€
401K
|
|
|
€
587K
|
€
388K
|
€
443K
|
€
394K
|
|
|
€
1.86M
|
€
1.87M
|
€
260K
|
€
213K
|
|
|
€
5.56M
|
€
4.01M
|
€
2.44M
|
€
2.18M
|
|
|
61.63%
|
48.40%
|
39.35%
|
38.05%
|
|
|
€
3.46M
|
€
4.28M
|
€
3.76M
|
€
3.54M
|
|
|
€
55K
|
€
107K
|
€
518K
|
€
156K
|
Publications 16
All publications- Ontslagen - Benoemingen 24/09/2021
- Kapitaal - Aandelen 09/01/2018
- Ontslagen - Benoemingen 14/02/2017
- Me. - Jaarrekening 31.12.2015, Ggk 06.06.2016, Ngl 20.06.2016 16199-0096-014 23/06/2016
- Me. - Jaarrekening 31.12.2014, Ggk 30.06.2015, Ngl 21.08.2015 15443-0074-013 24/08/2015
Frequently asked questions
Answers to the most common questions about Pharis, based on official government data and the filed annual accounts.
What is the VAT number of Pharis?
The VAT number of Pharis is BE0869.718.331.
When was Pharis established?
Pharis was founded in 28-10-2004.
What is the official address of Pharis?
The official address of Pharis is Sint-Andriesdreef 8 Brugge 8200.
What is the legal form of Pharis?
The juridical form of Pharis is Public limited company (NV/SA).
What is the annual revenue of Pharis?
The 2025 accounts of Pharis do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Pharis do?
PHARIS is a company specializing in the development and commercialization of innovative pharmaceutical products. It focuses on enhancing patient care through research and advanced healthcare solutions. The company aims to address unmet medical needs and improve treatment outcomes across various therapeutic areas.
Is Pharis a reliable company?
Pharis is a registered Rechtspersoon with company number 0869.718.331 and can be verified through the official CBE database.
What is the credit limit of Pharis?
The estimated credit limit of Pharis is €817,944.
Is Pharis still active?
Pharis currently has the status "Normal situation" and is active.